• Publications
  • Influence
Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies.
The vaccination of wild animals against rabies has been developed most extensively in Europe. Experiments have demonstrated the efficacy of a vaccinia-rabies recombinant virus administered by theExpand
  • 64
  • 4
Efficacy studies on a canarypox-rabies recombinant virus.
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge inExpand
  • 153
  • 3
Recombinant fowlpox virus inducing protective immunity in non-avian species.
The natural host of fowlpox virus is limited to avian species. When inoculated into non-avian tissue culture cells, however, fowlpox virus can initiate an abortive infection. A fowlpox virus wasExpand
  • 192
  • 2
Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.
A cDNA copy of the RNA encoding the fusion (F) protein of Newcastle disease virus (NDV) strain Texas, a velogenic strain of NDV, was obtained and the sequence was determined. The 1,792-base-pairExpand
  • 116
  • 2
Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America.
During recent years, most research on the control of sylvatic rabies has concentrated on developing methods of oral vaccination of wild rabies vectors. To improve both the safety and the stability ofExpand
  • 84
  • 2
Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.
The equine herpesvirus 1 glycoprotein 14 (EHV-1 gp14) gene was cloned, sequenced, and expressed by vaccinia virus recombinants. Recombinant virus vP613 elicited the production of EHV-1-neutralizingExpand
  • 47
  • 2
  • PDF
Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
The equine herpesvirus 1 (EHV-1) gene encoding glycoprotein 13 (gp13) was cloned into the hemagglutinin (HA) locus of vaccinia virus (Copenhagen strain). Expression of the gp13 gene was driven by theExpand
  • 68
  • 1
Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route.
The primary multiplication site of VVTGgRAB, a recombinant vaccinia virus (VV) expressing the rabies virus G glycoprotein, was studied in comparison with that of the parental VV Copenhagen strain,Expand
  • 52
  • 1
  • PDF
Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes, L) against rabies.
Thirteen fox cubs were orally administered 10(7.2) plaque-forming units of live vaccinia-rabies glycoprotein recombinant virus. On Day 28 post-vaccination, all but 1 cub had produced rabies virusExpand
  • 49
  • 1
Experimental rabies infection and oral vaccination in vampire bats (Desmodus rotundus).
A rabies virus variant isolated from a vampire bat (Desmodus rotundus) and characterized by genome sequencing was used for the standardization of an experimental infection in this species. TheExpand
  • 71
  • 1
  • PDF